VIVOS THERAPEUTICS INC (VVOS)
US92859E2072 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to VVOS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.43. This target is 51.2% above the current price.
VVOS was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VVOS.
In the previous month the buy percentage consensus was at a similar level.
VVOS was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-20 | Ascendiant Capital | Reiterate | Buy -> Buy |
| 2024-11-19 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-08-20 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2023-01-17 | Ascendiant Capital | Initiate | Buy |
| 2021-08-13 | Roth Capital | Maintains | Buy |
| 2021-05-18 | Roth Capital | Maintains | Buy |